Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients: Treatment Response Rates and Value of Early Surveillance Biopsies

Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients: Treatment Response Rates and Value of Early Surveillance Biopsies

Background. There is limited information on the value of short-term invasive and noninvasive monitoring in kidney transplant recipients (KTR) undergoing therapy for chronic active antibody-mediated rejection (cAMR). Methods. We describe response rates in patients with cAMR receiving pulse steroids/I...

Full description

Bibliographic Details
Main Authors: Fahad Aziz, MD, Sandesh Parajuli, MD, Margaret Jorgenson, PharmD, BCPS, Neetika Garg, MD, Venkata Manchala, MD, Elsadiq Yousif, MD, Didier Mandelbrot, MD, Luis Hidalgo, PhD, Maha Mohamed, MD, Weixiong Zhong, MD, Arjang Djamali, MD
Format: Article
Language:English
Published: Wolters Kluwer 2022-09-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001360

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001360

Similar Items